Literature DB >> 31039424

Neurologic complications in children under five years with sickle cell disease.

Aisha A Galadanci1, Michael R DeBaun2, Najibah A Galadanci3.   

Abstract

INTRODUCTION: Sickle Cell Disease (SCD) is one of the most common genetic diseases in the world affecting every organ. The major challenge in the medical care of children with SCD is preventing end-organ dysfunction, particularly the brain. Major neurologic complications in children less than five years with SCD include, but are not limited to, Silent cerebral infarct, cerebral sinus thrombosis, epilepsy, reversible encephalopathy syndrome, and ischemic and hemorrhagic stroke. Recurrent headaches and migraine are not rare in children under five years with SCD. This review will focus on the neurologic complications and the description of the modifiable risk factors in children less than 5 years of age with emphasis on differences between high and low resource settings. AREAS COVERED: Neurologic complications of children under 5 years of age and the modifiable risk factors. The PUBMED database was searched using medical subject headings (MeSH) and keywords for articles regarding neurologic complications in children under 5 years of age.
CONCLUSION: Neurologic complications in children under five years of age with SCD may be more frequent than currently reported, among which Silent cerebral infarct and cognitive impairment are the most common.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Children under five years; Neurologic complications; Sickle cell disease

Mesh:

Year:  2019        PMID: 31039424      PMCID: PMC7147490          DOI: 10.1016/j.neulet.2019.04.030

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  79 in total

Review 1.  Managing sickle cell disease.

Authors:  Susan Claster; Elliott P Vichinsky
Journal:  BMJ       Date:  2003-11-15

2.  New plans for headache classification: ICHD-3.

Authors:  Jes Olesen
Journal:  Cephalalgia       Date:  2010-07-05       Impact factor: 6.292

3.  Neurocognitive development of young children with sickle cell disease through three years of age.

Authors:  Robert J Thompson; Kathryn E Gustafson; Melanie J Bonner; Russell E Ware
Journal:  J Pediatr Psychol       Date:  2002 Apr-May

Review 4.  Incidence, prevalence and aetiology of seizures and epilepsy in children.

Authors:  Peter Camfield; Carol Camfield
Journal:  Epileptic Disord       Date:  2015-06       Impact factor: 1.819

5.  Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).

Authors:  Najibah A Galadanci; Shehu Umar Abdullahi; Leah D Vance; Abdulkadir Musa Tabari; Shehi Ali; Raymond Belonwu; Auwal Salihu; Aisha Amal Galadanci; Binta Wudil Jibir; Halima Bello-Manga; Kathleen Neville; Fenella J Kirkham; Yu Shyr; Sharon Phillips; Brittany V Covert; Adetola A Kassim; Lori C Jordan; Muktar H Aliyu; Michael R DeBaun
Journal:  Am J Hematol       Date:  2017-06-15       Impact factor: 10.047

6.  Risk of stroke in children: ethnic and gender disparities.

Authors:  Heather J Fullerton; Yvonne W Wu; Shoujun Zhao; S Claiborne Johnston
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

7.  Pseudotumor cerebri in children with sickle cell disease: a case series.

Authors:  Michael Henry; M Catherine Driscoll; Marijean Miller; Taeun Chang; Caterina P Minniti
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

8.  Genetic modifiers of severity in sickle cell disease.

Authors:  Alicia K Chang; Carly C Ginter Summarell; Parendi T Birdie; Vivien A Sheehan
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

9.  Neurological complications of sickle cell disease in Africa: protocol for a systematic review.

Authors:  Michel K Mengnjo; Joseph Kamtchum-Tatuene; Nicolas Nicastro; Jean Jacques N Noubiap
Journal:  BMJ Open       Date:  2016-10-19       Impact factor: 2.692

10.  Precursors of executive function in infants with sickle cell anemia.

Authors:  Alexandra M Hogan; Paul T Telfer; Fenella J Kirkham; Michelle de Haan
Journal:  J Child Neurol       Date:  2012-08-01       Impact factor: 1.987

View more
  3 in total

Review 1.  Association of Anemia With Epilepsy and Antiepileptic Drugs.

Authors:  Jaskamal Padda; Khizer Khalid; Mohammad Syam; Varsha Kakani; Gauvain Kankeu Tonpouwo; Richa Dhakal; Sandeep Padda; Ayden Charlene Cooper; Gutteridge Jean-Charles
Journal:  Cureus       Date:  2021-11-07

2.  Incidence of eye complications among sickle cell disease patients in Jeddah, Saudi Arabia: A cross-sectional study.

Authors:  Eid Ayed Almasoudi; Sultan Fahad Magliah; Abubakr Salem Alzwaihri; Abdullah Omar Aljuwaybiri; Abdullah Saleh Alqahtani
Journal:  Ann Med Surg (Lond)       Date:  2022-06-21

3.  Trial design of comparing patient-specific versus weight-based protocols to treat vaso-occlusive episodes in sickle cell disease (COMPARE-VOE).

Authors:  Stephanie O Ibemere; Sarah B Dubbs; Huiman X Barnhart; Jacqueline L Brown; Caroline E Freiermuth; Patricia Kavanagh; Judith A Paice; John J Strouse; R Gentry Wilkerson; Paula Tanabe
Journal:  Contemp Clin Trials       Date:  2020-12-28       Impact factor: 2.226

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.